Amino acids injure mesangial cells by advanced glycation end products, oxidative stress, and protein kinase C

Kidney International

Volumn 67, Issue 3, 2005, Pages 953-968

  Tuttle, Katherine R ^a   Johnson, Emily C ^b   Cooney, Sheryl K ^b   Anderberg, Robert J ^b   Johnson G, Edward K ^b   Clifton, Dennis ^b   Meek, Rick L ^b  

^a Heart Institute of Spokane   (United States)

^b NONE

Author keywords

Diabetic nephropathy; Fibrosis; High protein diet; Hyperglycemia; Mitogen activated protein kinases

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALANINE; ALPHA TOCOPHEROL; AMINO ACID; AMINOGUANIDINE; ARGININE; CYSTINE; GLUCOSE; GLUTAMINE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHENYLALANINE; PROLINE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE; ANTIOXIDANT;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DAMAGE; CONTROLLED STUDY; ENZYME ACTIVITY; GLYCATION; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; MESANGIUM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INTAKE; RAT; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; FEMALE; FIBROSIS; MESANGIUM; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

AMINO ACIDS; ANIMALS; ANTIOXIDANTS; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FIBROSIS; GLOMERULAR MESANGIUM; GLYCOSYLATION END PRODUCTS, ADVANCED; OXIDATIVE STRESS; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY;

EID: 16844369727     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00159.x     Document Type: Article

References (51)

1. US RENAL DATA SYSTEM: Annual Data Report: Incidence & Prevalence: Am J Kidney Dis 42(Suppl 5):S47-S60, 2003
2. FACTS ABOUT DIABETES: World Health Organization Diabetes Programme, available at http://www.who.int/diabetes (accessed April 30, 2004)
3. WRONE EM, CARNETHON MR, PALANIAPPAN L, FORTMANN SP: Association of dietary protein intake and microalbuminuria in healthy adults: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41:550-587, 2003
4. PEDRINI MT, LEVEY AS, LAU J, et al: The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: A meta-analysis. Ann Intern Med 124:627-632, 1996
5. KASISKE BL, LAKATUA JD, MA JZ, LOUIS TA: A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 31:954-961, 1998
6. AGASTON A: The South Beach Diet: The Delicious, Doctor-Designed, Foolproof Plan for Fast and Healthy Weight Loss, New York, NY, Rodale Press, 2003
7. ATKINS RC: Dr. Atkins' New Diet Revolution (expanded edition), New York, NY, M. Evans and Company, Inc., 2002
8. STEWARD HL, BETHEA MC, ANDREWS SS, BALART LA: The New Sugar Busters (revised and updated edition), New York, NY, Ballantine Books, 2002
9. EADES MR, EADES MD: Protein Power: The High-Protein/Low Carbohydrate Way to Lose Weight, Feel Fit, and Boost Your Health-In Just Weeks, New York, NY, Bantam Books, 1997
10. ZATZ R, MEYER TW, RENNKE HG, BRENNER BM: Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 82:5963-5967, 1985
11. HOSTETTER TH, MEYER TW, RENNKE HG, BRENNER BM: Chronic effects of dietary protein in the rat with intact and reduced renal mass. Kidney Int 30:509-517, 1986
12. TUTTLE KR, BRUTON JL, PERUSEK MC, et al: Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus. N Engl J Med 324:1626-1632, 1991
13. TUTTLE KR, BRUTON JL: Effect of insulin therapy on renal hemodynamic response to amino acids and renal hypertrophy in non-insulin-dependent diabetes. Kidney Int 42:167-173, 1992
14. TUTTLE KR, PUHLMAN ME, COONEY SK, SHORT RA: Effects of amino acids and glucagon on renal hemodynamics in type 1 diabetes. Am J Physiol Renal Physiol 282:F103-F112, 2002
15. MEEK RL, COONEY SK, FLYNN SD, et al: Amino acids induce indicators of response to injury in glomerular mesangial cells. Am J Physiol Renal Physiol 285:F79-F86, 2003
16. CHOUINARD RF, MEEK RL, COONEY SK, TUTTLE KR: Effects of amino acids and glucose on mesangial cell aminopeptidase a and angiotensin receptors. Kidney Int 61:S106-S109, 2002
17. BROWNLEE M: Negative consequences of glycation. Metabolism 49:89-813, 2000
18. BROWNLEE M: Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820, 2001
19. NISHIKAWA T, EDELSTEIN D, DU XL, et al: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790, 2000
20. SCIVITTARO V, GANZ MB, WEISS MF: AGEs induce oxidative stress and activate protein kinase C-βII in neonatal mesangial cells. Am J Physiol Renal Physiol 278:F676-F683, 2000
21. WHITESIDE CI, DLUGOSZ JA: Mesangial cell protein kinase C isozyme activation in the diabetic milieu. Am J Physiol Renal Physiol 282:F975-F980, 2002
22. CHEN S, COHEN MP, LAUTENSLAGER GT, et al: Glycated albumin stimulates TGF-β1 production and protein kinase C activity in glomerular endothelial cells. Kidney Int 59:673-681, 2001
23. ISONO M, IGLESIAS-DE LA CRUZ MC, CHEN S, et al: Extracellular signal-regulated kinase mediates stimulation of TGF-β1 and matrix by high glucose in mesangial cells. J Am Soc Nephrol 11:2222-2230, 2000
24. HUA H, GOLDBERG HJ, FANTUS IG, WHITESIDE CI: High glucose-enhanced mesangial cell extracellular signal-regulated protein kinase activation and α1(IV) collagen expression in response to endothelin-1. Diabetes 50:2376-2383, 2001
25. AOKI TT, BRENNAN MF, MÜLLER WA, et al: Amino acid levels across normal forearm muscle and splanchnic bed after a protein meal. Am J Clin Nutr 29:340-350, 1976
26. FARISS MW, NICHOLLS-GRZEMSKI FA, TIRMENSTEIN MA, ZHANG JG: Enhanced antioxidant and cytoprotective abilities of vitamin E succinate is associated with a rapid uptake advantage in rat hepatocytes and mitochondria. Free Radic Biol Med 31:530-541, 2001
27. DAISUKE K, JIROUSEK MR, LIN YW, et al: Characterization of protein kinase C β isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115-126, 1997
28. PFAFF IL, VALLON V: Protein kinase C beta isoenzymes in diabetic kidneys and their relation to nephroprotective actions and the ACE inhibitor lisinopril. Kidney Blood Press Res 25:329-340, 2002
29. GUO M, WU MH, KOROMPAI F, YUAN SY: Upregulation of PKC genes and isozymes in cardiovascular tissues during early stages of experimental diabetes. Physiol Genomics 12:139-146, 2002
30. PARK HY, RUSSAKOVSKY V, OHNO S, GILCHREST BA: The β isoform of protein kinase C stimulates human melanogenesis by activating tyrosinase in pigment cells. J Biol Chem 268:11742-11749, 1993
31. 1 rat pituitary cells. J Biol Chem 265:15704-15712, 1990
32. KNIGHT EL, STAMPFER MJ, HANKINSON SE, et al: The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency. Ann Intern Med 138:460-467, 2003
33. BRENNER BM, MEYER TW, HOSTETTER TH: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307:652-659, 1982
34. RUILOPE LM, CASAL MC, PRAGA M, et al: Additive antiproteinuric effect of converting enzyme inhibition and a low protein intake. J Am Soc Nephrol 3:1307-1311, 1992
35. GANSEVOORT RT, DE ZEEUW D, DE JONG PE: Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease. Nephrol Dial Transplant 10:497-504, 1995
36. O'DONNELL MP, KASISKE BL, SCHMITZ PG, KEANE WF: High protein intake accelerates glomerulosclerosis independent of effects on glomerular hemodynamics. Kidney Int 37:1263-1269, 1990
37. PETERS H, BORDER WA, NOBLE NA: Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis. Kidney Int 57:1493-1501, 2000
38. MANN GE, YUDILEVICH DL, SOBREVIA L: Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 83:183-252, 2003
39. FU S, FU M, BAYNES JW, et al: Presence of DOPA and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): Amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins. Biochem J 330:233-239, 1998
40. TUTTLE KR, ANDERSON PW: A novel potential therapy for diabetic nephropathy and vascular complications: Protein kinase C β inhibition. Am J Kidney Dis 42:456-465, 2003
41. ONO Y, KIKKAWA U, OGITA K, et al: Expression and properties of two types of protein kinase C: Alternative splicing from a single gene. Science 236:1116-1120, 1987
42. ANDERSON MM, REQUENA JR, CROWLEY JR, et al: The myeloperoxidase system of human phagocytes generates N-epsilon-(carboxymethyl)lysine on proteins: A mechanism for producing advanced glycation end products at sites of inflammation. J Clin Invest 104:103-113, 1999
43. PITHON-CURI TC, LEVADA AC, LOPES LR, et al: Glutamine plays a role in superoxide production and the expression of the p47phox, p22phox and gp91phox in rat neutrophils. Clin Sci 103:403-408, 2002
44. ZHANG F, SIOW YL, KARMIN O: Hyperhomocysteinemia activates NF-κB and inducible nitric oxide synthase in the kidney. Kidney Int 65:1327-1338, 2004
45. VYCHYTIL A, FÖDINGER M, PLEINER J, et al: Acute effect of amino acid peritoneal dialysis solution on vascular function. Am J Clin Nutr 78:1039-1045, 2003
46. LAL MA, BRISMAR H, EKLOF AC, APERIA A: Role of oxidative stress in advanced glycation end product-induced mesangial cell activation. Kidney Int 61:2006-2014, 2002
47. NILSSON BO: Biological effects of aminoguanidine: An update. Inflamm Res 48:509-515, 1999
48. AZZI A, RICCIARELLI R, ZINGG JM: Non-antioxidant molecular functions of α-tocopherol (vitamin E). FEBS Lett 519:8-10, 2002
49. SHEN GX, WAY KJ, JACOBS JR, KING GL: Applications of inhibitors for protein kinase C and their isoforms. Methods Mol Biol 233:397-422, 2003
50. VLASSARA H, CAI W, CRANDALL J, et al: Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci USA 99:15596-15601, 2002
51. ZHENG F, HE C, CAI W, et al: Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products. Diabetes Metab Res Rev 18:224-237, 2002